Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-03-31

Clinical Trial Update: Effect of NeuroAD on the Cognitive Function of Alzheimer Patients [NA]

View source ↗

Summary

Clinical trial update indicating the completion of a study evaluating NeuroAD for cognitive function in Alzheimer's disease patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NeuroAD

Snippet

Sponsor: Neuronix Ltd | Conditions: Alzheimer's Disease | NA | Status: COMPLETED